Exelixis
EXEL
$23.70
Share price
0.72%
Change (1 day)
30.43%
Change (1 year)
Categories
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.
Exelixis (EXEL) - Cost to borrow shares
Latest borrow fee for Exelixis (EXEL) shares on Interactive Brokers: 0.3627% (annualized)
Shares available to borrow: 2800000The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.
Exelixis (EXEL) - cost to borrow in the last 7 days chart
Exelixis (EXEL) - number of shares available to borrow in the last 7 days
Exelixis (EXEL) - cost to borrow from 2024 to 2023
Exelixis (EXEL) - number of shares available to borrow from 2024 to 2023
Cost to borrow for shares of similar companies or competitors
| Company | Cost to borrow (% year) | Shares available | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 0.4081% | 8.2 M | 🇺🇸 USA |
 Pfizer PFE | 0.4186% | 10 M | 🇺🇸 USA |
 Amgen AMGN | 0.4081% | 2.8 M | 🇺🇸 USA |
 Sanofi SNY | 0.419% | 0.55 M | 🇫🇷 France |
 Merck MRK | 0.2552% | 10 M | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 0.25% | 10 M | 🇺🇸 USA |
 GlaxoSmithKline GSK | 0.25% | 2 M | 🇬🇧 UK |
 Curis CRIS | 8.2232% | 0.35 M | 🇺🇸 USA |